(NASDAQ: IFRX) Inflarx Nv's forecast annual revenue growth rate of 981.24% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.68%.
Inflarx Nv's revenue in 2023 is $64,003.On average, 3 Wall Street analysts forecast IFRX's revenue for 2023 to be $407,060,059, with the lowest IFRX revenue forecast at $93,624,402, and the highest IFRX revenue forecast at $876,183,087. On average, 3 Wall Street analysts forecast IFRX's revenue for 2024 to be $2,372,995,862, with the lowest IFRX revenue forecast at $946,254,181, and the highest IFRX revenue forecast at $4,602,905,372.
In 2025, IFRX is forecast to generate $4,848,801,916 in revenue, with the lowest revenue forecast at $1,726,457,535 and the highest revenue forecast at $9,679,821,084.